Literature DB >> 1849945

Peripheral analgesic actions of opioids.

C Stein.   

Abstract

This paper will review experimental and clinical studies investigating analgesic effects of opioids outside the central nervous system. The experimental data indicate that 1) opioids can produce antinociceptive effects in the periphery mediated by local opioid receptors, 2) three different receptor types (mu, delta, kappa) can become active in peripheral tissue, 3) inflammatory hyperalgesic conditions are especially amenable to peripheral opioid actions and 4) the activation of opioid receptors located on primary afferent neurons is the most likely mechanism of action. The evidence from clinical studies is equivocal so far, partly because of methodological shortcomings. More extensive controlled studies investigating the effects of local application of opioids in the vicinity of peripheral nerve terminals or of compounds unable to cross the blood-brain barrier are warranted in view of the potential avoidance of central side effects such as respiratory depression, dependence, nausea or sedation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1849945     DOI: 10.1016/0885-3924(91)90960-c

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  7 in total

1.  Dissociation of tolerance and dependence for opioid peripheral antinociception in rats.

Authors:  K O Aley; J D Levine
Journal:  J Neurosci       Date:  1997-05-15       Impact factor: 6.167

2.  Different mechanisms mediate development and expression of tolerance and dependence for peripheral mu-opioid antinociception in rat.

Authors:  K O Aley; J D Levine
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

3.  Peripheral opioid analgesia in teeth with symptomatic inflamed pulps.

Authors:  R A Uhle; A Reader; R Nist; J Weaver; M Beck; W J Meyers
Journal:  Anesth Prog       Date:  1997

4.  The efficacy of locally applied morphine in post-operative pain after bilateral third molar surgery.

Authors:  U J Moore; R A Seymour; J Gilroy; M D Rawlins
Journal:  Br J Clin Pharmacol       Date:  1994-03       Impact factor: 4.335

Review 5.  Kappa opioids and the modulation of pain.

Authors:  Bronwyn Kivell; Thomas E Prisinzano
Journal:  Psychopharmacology (Berl)       Date:  2010-04-07       Impact factor: 4.530

Review 6.  The interpersonal dimension of borderline personality disorder: toward a neuropeptide model.

Authors:  Barbara Stanley; Larry J Siever
Journal:  Am J Psychiatry       Date:  2009-12-01       Impact factor: 18.112

7.  The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration.

Authors:  J L Wilson; V Nayanar; J S Walker
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.